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Objectives: This study summarizes the effects of treatment of complicated PE.Methods: In
the period of 2004–2010, 11 children with PE aged 1–19 needed surgical treatment. Before
having been referred to our department, all children were managed for sustained pneu-
monia by local pediatricians using broad-spectrum antibiotics. Next, children were inef-
fectively treated in general hospitals using conventional pleural drainagesmaintained for
1 week to 2 months. Results: In 7 cases, a single video-assisted thoracoscopy (VATS),
debridement, placement of pleural tubes under visual control, active suction drainage,
and rehabilitation resulted in lung expansion, efficient ventilation, rapid relief of symp-
toms, and full recovery. Starting from the 2nd post-operative day, all children received
fibrinolytics 3–6 times via chest tubes. In 3 patients, lack of lung expansion made the
second VATS debridement necessary. In 1 patient in organizing stage of PE, re-VATS was
supported by mini-thoracotomy allowing effective decortication and lung expansion. The
average hospitalization time was 17 days. Surprisingly, even in the most neglected
patients of our group, the follow-up CT scans done 3–4 months after discharge, were
almost uneventful. The majority of spirometric parameters normalized within 6 months,
and no child claimed dyspnoe due to physical strain. Conclusions: Early VATS combined
with early rehabilitation offers excellent results, radically improving the outcome in both
the fibrinopurulent, as well as in organizing stages of PE in children, nonetheless surgeon
should be experienced in the minimally invasive technique. The method seems to be
successful even in very neglected cases, if not, patient could benefit from fibrinolytic
therapy.
© 2012 Polish Pediatric Society. Published by Elsevier Urban & Partner Sp. z o.o.
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Introduction
Pleural effusions are common complications of pediatric
bacterial pneumonias. Improving pediatric care does not
eliminate pleural empyema (PE) – a life-threatening condition
which may also result in the permanent deterioration of lung
function. There is debate about treatment options. Simple
chest tube drainage is often inadequate in complicated
parapneumonic effusions due to presence of viscous fluid
with fibrinous debris clogging the tube [1]. Patients with poor
response to antibiotics and tube thoracostomy may require
surgical decortications [1, 2]. Length of stay and long-term
morbidity are reduced by this more aggressive approach.
Video-assisted thoracoscopic surgery (VATS) closely imitates
open thoracotomy and drainage, and is an effective and less-
invasive replacement for the decortications procedure [3].
Materials and methods
We performed a retrospective review of the records of 11
consecutive patients who needed surgical treatment because
of pleural empyema in regional referral children’s hospital
between January 2004, and December 2010. There were 4 boys
and 7 girls, and all had postpneumonic empyemas. Their ages
ranged from 1 to 19 years (mean 8.9). Before having been
referred to our department, all children were managed for
sustained pneumonia by local pediatricians using broad-
spectrum antibiotics for 1 to 9 weeks (mean 3 weeks). Next,
children were ineffectively treated in general hospitals using
conventional pleural drainages maintained for 1 day to
2 months (mean 12 days). On the admission three youngest
children – boys aged 1, and 4, and girl aged 1 showed clinical
signs and symptoms of a septic condition. All patients
had anteroposterior and lateral chest radiographs and all
patients had computed tomographic scans to guide interven-
tional procedures (Figs. 1–5). VATS is performed under general
anesthesia. Intra-operative monitoring includes an arterial
pressure line, large bore intravenous access, a Foley catheter,
and pulse oximetry. The patient is positioned as for
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Fig. 2 – pleural empyema – 1,5-year-old boy – CT on the
admission
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Fig. 3 – pleural empyema – 1,5-year-old boy – CT after first
VATS
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and fibrinolytic treatmenta posterolateral thoracotomy. The camera port is placed in
the 7th or 6th intercostal space in the line of the anterior
superior iliac spine or just anterior to this. VATS decortication
can be performed through 2 or 3 ports. The working port
should be placed over the 5th intercostal space between the
mid and anterior axillary lines. The intercostal incision should
allow 3 fingers. A third port can be placed posteriorly,
positioned to allow access to the anterior part of the pleural
cavity. Once the chest is entered, a suction is used to drain the
chest of effusion. The preoperative CT scan helps guide this
‘blind’ initial drainage and creates a working pleural space for
the thoracoscopic instruments. Gelatinous fibrinous deposits
are removed with a curved ring forceps clips. The visceral
pleural peel can be debrided using ring-forceps and a dissector
as in an open decortication. Once a pleural space has been
created the removal of fibrinousmaterial is performed starting
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Fig. 5 – pleural empyema – 1,5-year-old boy – X-ray after
second VATS and fibrinolytic treatment
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Fig. 4 – pleural empyema – 1,5-year-old boy – X-ray after
VATS and fibrinolytic treatment
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vice versa. The sucker and ring clamp are used together to
remove the fibrinous material from the pleural cavity.
Intermittent ventilation of the lung is used to assess the
completeness of the decortication as the dissection proceeds.
If adequate progress is not being made or there is inadequate
expansion of the lung to fill the chest, then conversion to open
decortication should be performed. Particular care should be
taken with hemostasis both on the parietal and visceral
pleura. Once adequate debridement has been accomplished,
irrigation is performed and the lung expansion is visualized toensure the pleural cavity is filled by the lung. Chest tubes can
be placed anteriorly and posteriorly for air and fluid drainage.
The chest tubes are maintained on suction to make sure there
is complete lung expansion and adequate drainage of the
pleural space
In all 11 children a video-assisted thoracoscopic surgery
(VATS) with debridement, and placement of pleural tubes
under visual control was performed. In every case the lung
expansion was partial after VATS, despite of active suction
and drainage (Figs. 2 and 5). Starting from the 2nd post-
operative day, all children received fibrinolytics once daily for
2–4 days via chest tubes. The fibrynolytic agents used for
treatment were urokinase (UK) in 2 cases and streptokinase
(SK) in the rest. Urokinase was used for procedures performed
after 2007 year. The tube was clamped for 1 h and then left
open and connected to awater seal device and placed to 15 cm
H2O suction. The fibrinolytic agent was diluted in 10–50 ml
of normal saline, with the volume arbitrarily selected on
the basis of patient age and size and estimated volume of the
pleural space to be treated. Treatment doses of streptokinase
ranged from 12,000 IU to 250,000 IU, and treatment doses of
urokinase were 50.000 IU (children weighing about 60 kg – to
produce a concentration of 1.000 IU/ml). The activated partial
thromboplastin time, prothrombin time, and hemogramwere
determined routinely before instillation of the fibrinolytic
agent. The vital signs were closely observed. Fever and chest
pain observed in two cases after use of streptokinase, was not
noted after urokinase. The discomfort was easily managed by
the administration of acetaminophen. Daily anteroposterior
chest radiographs were obtained with the patient in an
upright or semiupright position. Fibrinolytic treatments were
continued until chest radiographs showed improvement
(Figs. 4 and 5). In 3 patients, lack of lung expansion made
the second VATS debridement necessary. In 1 patient in
organizing stage of PE, re-VATS was supported by mini-
thoracotomy allowing effective decortication. Again children
received fibrinolytics once daily for 3 days via chest tubes.
Results
No child required lung resection. The mean duration of
fibrinolytic instillation was 3.4 days (range 2 to 6), and the
meanduration of chest tube drainagewas 18.6 days (5–27). The
average hospitalization timewas 22.3 days (7–32). The amount
of drainage via the thoracic tube after instillation of the
fibrinolytic agent was 30–150 ml per day (mean 69 ml). No
complications occurred during the treatment, and there was
no evidence of hemorrhage. Surprisingly, even in the most
neglected patients of our group, the follow-up CT scans done
3–4 months after discharge, were almost uneventful. The
majority of spirometric parameters normalized within
6 months, and no child claimed dyspnoe due to physical
strain.
Discussion
Parapneumonic effusions occur in as many as 50–70% of
patients admitted with a complicated pneumonia [4–6]. Most
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microbials of sufficient duration resolve without the deve-
lopment of complications. Usually in exudative stage,
antibiotics and thoracentesis or tube thoracostomy result in
cure [4–6]. Complicated parapneumonic effusions in which
a pleural peel is created and fibroblast proliferation result
in parenchymal entrapment, require surgical intervention
[1, 4–6]. Intrapleural instillation of a fibrinolytic agent to
accelerate drainage of a loculated effusionwasfirst reported in
the 1950s [7]. Urokinase was introduced in 1987 and became
the most frequently used agent for fibrinolysis because of
concerns about the antigenicity of streptokinase [1, 2, 6]. The
fibrinolytic agent degrades a variety of proteins, including
fibrin and fibrin blood clots. The fibrinolytic reaction is the
result of streptokinase or urokinaze mediated enzymatic
activation of the plasminogen-streptokinaze or -urokinaze
complex to plasmin. Using fibrynolytics improved the care of
the complicated empyema by improved management of
loculations and amelioration of fibrous peel formation and
fibrin deposition [1, 2, 6]. We haven’t found in the literature
descriptions of combined therapy for pleural empyemas with
the use of VATS and fibrynolitics. There are reports with
comparison of urokinaze andVATS for treatment of childhood
empyema [7]. Probably the lack of technique lead to partial
expansion of the lung in our cases. After VATS our patient
benefited from fibrinolytic therapy combined with early
rehabilitation. All before admitting to our Clinic were
ineffectively treated in general hospitals using conventional
pleural drainages maintained for 1 day to 2 months (mean 12
days). Before the admission to our Clinic 8 of 11 our patients
have had done radiologic examination – upright views of the
chest. After admission to our Clinic all of them had chest CT
imaging to define pleural fluid, image the airways and guide
interventional procedures. After that debridement and pla-
cement of pleural tubes during VATS was performed in all 11
children. Most specimens cultured were sterile, probably
because of the use of oral antibiotics before the recognition of
the parapneumonic effusion. Streptococcus pneumonia was
isolated in one patient and Staphylococcus aureus MSSA –
methicillin susceptible – also in one patient. In every case the
lung expansion was partial after VATS, despite of active
suction drainage, and rehabilitation. Starting from the 2nd
post-operative day, all children received fibrinolytics for 2–6
days via chest tubes. In the literature problems encountered
with the use of fibrinolytics were allergic reactions and
antibody neutralization of the fibrinolytic agent during
prolonged therapy [1, 8]. Serious complications from fibrino-
lytic treatment did not occur in this series. In our series the
small percentage of patients required second VATS and one
VATS was supported by mini-thoracotomy. Those patients in
which combined VATS and fibrinolytic therapy had beenmost
effective were those slightly less affected, in whomearlier and
more aggressive treatment had been initiated. The treatment
of patients who have pediatric empyema by using thoracos-
tomy tube drainage alone is reported to have primary success
rate of 32–89% [8–11]. Reported average lengths of hospitali-
zation range from 20 to 23 days [8–11]. Treatment of
fibropurulent empyema in children with thoracoscopy is
reported to be associated with average hospitalizations
of 7–25 days, average thoracostomy tube dwell times of3–21 days, and treatment success rates of 89%–100% [3, 8, 12].
Among our patients VATS combined with use of fibrinolytics
resulted in 100% success rate. The thoracostomy tube dwell
time for our patients was 4–27 days (mean 18.6 days), and the
hospitalization time was 7–32 days (mean 22.3 days). When
the empyema is in the exudative or fibrinopurulent stage and
has been present for approximately 3 weeks duration or less,
thoracoscopic intervention is usually successful. When the
empyema has been present for longer than 3 weeks (orga-
nizing phase) as in our patients, the ability to perform an
adequate decortication may be more difficult due to denser
adhesions and the presence of an adherent pulmonary
visceral peel [13, 14]. Also the lack of experience – the study
was retrospectively performed on 11 patients, may be the
cause of the fact that in our 3 patients the second VATS
debridement was necessary. Patients with an exudative or
fibrinopurulent empyema can almost always be approached
with thoracoscopy. Conversion to open thoracotomy is
performed when necessary and should not be considered
a failure of thoracoscopy, but rather as a mature surgical
judgment as in our youngest patient. CT scan of the chest
provides information on the location, degree of location, the
extent of the empyema, and the underlying lung parenchyma.
It is not unusual for an organism not to be identified on the
pleural fluid culture and therefore broad-spectrum antibiotic
coverage should be institutedwhen the diagnosis of empyema
is made. This can be modified if the culture data identifies an
organism.
Conclusions
Early VATS combined with early rehabilitation offers excel-
lent results, radically improving the outcome in both the
fibrinopurulent, as well as in organizing stages of PE in
children, but surgeon should be experienced in the less
invasive technique. The method seems to be successful even
in very neglected cases, if not patient could benefit from
fibrinolytic therapy.
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